(Q71948856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

W Rhomberg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

E O Hassenstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

D Gefeller

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

1077-1084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

Clinical experiences with intraoperative radiotherapy of locally advanced cancers

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Recommendations for clinical protocol development and definition of therapeutic response for soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Cavitary pulmonary metastases in angiosarcoma. Diagnosis by transthoracic needle aspiration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

A clinical evaluation of ICRF 159 as a radiosensitising agent

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

ICRF-159: current status and clinical prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Malignant fibrous histiocytoma of soft tissue. An analysis of 78 cases located and deeply seated in the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

The continuing challenge of retroperitoneal sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Response of sarcomas of bone and of soft tissue to neutron beam therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Antitumour Activity in a Series of bisDiketopiperazines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Abscess formation in recurrent liposarcomas of the abdomen and retroperitoneum: Relevance to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Control of Malignant Metastases by ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Comparison of radiotherapy with and without razoxane (icrf 159) in the treatment of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Sarcomas of the distal extremities.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Does radiotherapy have a role in hemangiopericytoma management? Report of 14 new cases and a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Malignant fibrous histiocytoma a retrospective study of 167 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Clinical experience with intravenous radiosensitizers in unresectable sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Preliminary results of a randomized study of adjuvant radiation therapy in resectable adult retroperitoneal soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Surgery and postoperative radiotherapy in the treatment of soft tissue sarcomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Effectiveness of radiation therapy in the management of sarcoma of the soft somatic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

The role of radiotherapy in the management of malignant hemangiopericytoma.Report of eleven new cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Combined treatment of the Walker tumour with radiotherapy and ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Radiation therapy in the treatment of malignant fibrous histiocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Radiotherapy combined with ICRF 159 (NSC 129943)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Split-dose radiotherapy for radioresistant bone and soft tissue sarcoma: ten years' experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

The role of neutrons in the treatment of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Mode of Action of the Cytostatic Agent ‘ICRF 159’

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Radiation therapy for unresectable soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Impact of improved local control on survival in patients with soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Radiation therapy alone for sarcoma of soft tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Radiation therapy of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Radiation therapy of retroperitoneal soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

Cystic pulmonary metastatic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900433-6

7 January 2021

10.1016/S0360-3016(96)00433-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8985029%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference